Accelerated wound healing in diabetic ulcers by Sitagliptin

Trial Profile

Accelerated wound healing in diabetic ulcers by Sitagliptin

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 06 Oct 2016

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Acronyms SitaDFU
  • Most Recent Events

    • 14 Sep 2016 Status changed from recruiting to withdrawn prior to enrolment.
    • 12 Aug 2016 EudraCT reporting phase as phase IV . Kept as per NCT record by considering criterias like locations, primary end points, focus, patient no atc
    • 26 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top